Disclosure: Some links on this page are affiliate links. If you purchase through these links, we may earn a commission at no extra cost to you.

Find My GLP-1 Path

Affiliate disclosure: The RX Index earns a commission when you sign up with some of the providers mentioned on this page. It does not affect what you pay, and it never determines our rankings or which providers we cover. Read the full disclosure.

Provider Guide

Published:

GLP-1 Providers That Accept OptumRx: Who Can Actually Help You Use Your Pharmacy Benefit

By The RX Index Editorial Team — 8 providers compared · OptumRx 2026 coverage reviewed · Last verified: May 23, 2026 · Next audit: June 23, 2026

Affiliate disclosure: Some links on this page are affiliate links. We may earn a commission at no cost to you. This never changes what you pay, which providers we cover, or how we rank them.

GLP-1 Providers That Accept OptumRx: The Short Answer First

If you searched GLP-1 providers that accept OptumRx, here’s the honest answer up front: OptumRx is your pharmacy benefit manager (PBM), not a doctor’s office. So no telehealth provider “accepts OptumRx” the way an in-network doctor accepts your health plan. What actually matters is finding a provider that prescribes FDA-approved GLP-1s, submits prior authorization (PA) the right way, and sends the prescription to a pharmacy where OptumRx can process the claim.

For most commercial OptumRx members, Ro is the strongest first stop. Their free GLP-1 Insurance Coverage Checker reaches out to your insurance and returns a coverage report, and their insurance concierge submits prior authorization paperwork when needed. Sesame Care is the next-best alternative, especially for the new Wegovy pill (Sesame is a NovoCare Recognized Care Provider). Nurx is the only major GLP-1 provider we found that explicitly lists OptumRx by name in its insurance FAQ.

Two caveats most pages skip. If your employer plan requires Calibrate (or another structured weight-management program) before covering a GLP-1, you must start there first — no shortcuts. And if your plan flat-out excludes weight-loss drugs (more common than people realize), no telehealth provider can override that. We’ll show you exactly how to verify both in under 10 minutes, plus a clearly-labeled cash-pay fallback if neither path works.

Ro reaches out to your insurance and returns a written report. No prescription submitted, no commitment. (sponsored)

GLP-1 Providers That Accept OptumRx: 2026 Provider Fit Matrix

Eight major GLP-1 telehealth providers, scored against five OptumRx-specific criteria — whether they prescribe FDA-approved GLP-1s, whether they submit prior authorization, whether they have an active insurance concierge, whether they route prescriptions to OptumRx’s pharmacy network, and whether they offer a cash-pay fallback if your plan denies coverage.

ProviderPrescribes FDA-Approved GLP-1sSubmits Prior AuthActive Insurance ConciergeRoutes to OptumRx NetworkCash-Pay FallbackBest Fit
Ro✅ Wegovy pen, Wegovy pill, Zepbound pen, Zepbound KwikPen, Foundayo✅ Free Coverage Checker; concierge handles PA paperwork✅ Strongest in the category✅ Patient-preferred pharmacy incl. OptumRx Home Delivery✅ FDA-approved cash-pay optionsMost commercial OptumRx members
Sesame Care✅ Wegovy pill (NovoCare partner), Wegovy pen, Zepbound, Ozempic, Mounjaro, Foundayo, Saxenda✅ Success by Sesame providers complete PA paperwork⚠️ Only in Success by Sesame — not one-off visits✅ Patient pharmacy✅ From $149/month without insuranceProvider choice + Wegovy pill
Nurx✅ FDA-approved weight management medications✅ Care team handles PA⚠️ Listed; less aggressive than Ro✅ Patient pharmacy⚠️ Care fee is cash-pay onlyExplicit OptumRx listing
PlushCare✅ Wegovy, Zepbound, Ozempic✅ Doctors and care team submit PA⚠️ OptumRx network status not verifiable — confirm directly✅ Patient pharmacy❌ Brand-name onlyDoctor-visit feel
WeightWatchers Clinic (Med+)✅ Wegovy, Zepbound, Ozempic, Mounjaro✅ Insurance coordinators work commercial plans✅ Active✅ Patient pharmacy❌ Not centralCoaching + meds
Noom Med✅ Wegovy, Zepbound, Saxenda✅ Up to 14 days per Noom⚠️ Less aggressive than Ro✅ Patient pharmacy⚠️ State availability variesPsychology coaching style
Calibrate✅ FDA-approved GLP-1s✅ Full-service insurance navigation✅ Aggressive✅ Patient pharmacy❌ Heavier programOnly when your employer requires it
Eden / MEDVi❌ Compounded only — not FDA-approved❌ Cash-pay; no OptumRx interaction❌ N/A❌ Ships from compounding pharmacy✅ Cash fallback only (see disclosures)Cash-pay only when no FDA-approved path works

Sources: Ro (ro.co/weight-loss/insurance, ro.co/weight-loss/pricing, ro.co/weight-loss/glp1-insurance-checker); Sesame Care (sesamecare.com); Sesame × NovoCare Wegovy pill partnership (BusinessWire, January 2026); Nurx insurance and pricing FAQ; PlushCare GLP-1 prescription page; WeightWatchers Med+; Noom branded meds FAQ; OptumRx-hosted employer pages confirming Calibrate enrollment requirements on some plans; Eden terms of service; FDA warning letter to MEDVi LLC, February 20, 2026 (#721455).

Want Ro’s team to handle the insurance check? Start free → (sponsored affiliate link, opens in a new tab)(sponsored)

What “Accepts OptumRx” Actually Means (And Why Most Pages Get This Wrong)

OptumRx is a pharmacy benefit manager — the company that decides which prescriptions your plan pays for, at what tier, and with what prior-authorization rules. It is not a doctor’s office. So no telehealth provider “accepts OptumRx” the way an in-network doctor accepts a health plan. What providers actually do is three different things: write the prescription, submit prior authorization to OptumRx, and route your medication to a pharmacy where OptumRx processes the claim.

Three things “accepts OptumRx” might actually mean

  1. The provider writes a prescription for a drug on the OptumRx formulary. Almost every FDA-approved-only telehealth provider does this. It’s necessary, but not enough.
  2. The provider submits prior authorization to OptumRx. This is where the real work happens. Incomplete PAs are the #1 reason claims get denied. Ro, Sesame’s Success by Sesame, Nurx, PlushCare, WeightWatchers Clinic, Noom Med, and Calibrate all do this. Eden and MEDVi do not.
  3. The provider routes your prescription to your OptumRx-network pharmacy. This determines your copay. OptumRx Home Delivery (the mail-order pharmacy) often has the lowest copay. OptumRx Specialty Pharmacy may be required for some specialty-tier GLP-1s on some plans. Your local CVS, Walgreens, Costco, or grocery-store pharmacy can also process OptumRx claims.

The financial difference is real

With OptumRx coverage and an approved PA, most members pay $25–$200/month for Wegovy or Zepbound. Without coverage, the same medication runs $800–$1,400/month at retail. The provider you pick is the lever that can swing you between those two worlds.

Quick reality check most pages skip

OptumRx is owned by UnitedHealth Group and serves UnitedHealthcare members — but it also serves some non-UHC plans (some self-funded employer plans that carved out pharmacy to Optum, some ACA marketplace plans, some Medicaid managed-care plans). If your card shows OptumRx — whether your medical insurance is UHC or not — this guide is for you.

If you want the broader UHC view (medical visits, in-network billing, every UHC path), see our companion guide: GLP-1 With UnitedHealthcare: Every Path (2026). This page is the PBM-side counterpart.

Which OptumRx Member Are You? Match Your Situation in 30 Seconds

The right next step depends on what you already know about your plan. Picking the wrong one costs weeks and sometimes hundreds of dollars in membership fees you can’t get back.

If this is youStart here
I have commercial OptumRx and want help with prior authRo (free Coverage Checker)
I want FDA-approved options and provider choiceSesame Care (Success by Sesame)
I want a provider that explicitly lists OptumRx for medication insuranceNurx
My employer or OptumRx benefits page says Calibrate is requiredCalibrate first — no shortcuts
OptumRx says weight-loss meds are excluded on my planCheck exception paths below, then read our cash-pay section
Free 60-second OptumRx GLP-1 path quiz →

No email. Six quick questions and we’ll tell you exactly where to start.

Ro: Why It’s the Best First Stop for Most OptumRx Members

Ro is the only major GLP-1 telehealth provider with (a) a free GLP-1 Insurance Coverage Checker that reaches out to your insurance, (b) a dedicated insurance concierge that submits prior authorization paperwork, and (c) a full FDA-approved formulary — Wegovy pen, Wegovy pill, Zepbound pen, Zepbound KwikPen, and Foundayo — at cash prices matching LillyDirect, NovoCare, and TrumpRx if your OptumRx plan doesn’t cover the medication.

What Ro actually does with your OptumRx info

  1. You enter your insurance details into Ro’s free GLP-1 Insurance Coverage Checker (no prescription, no commitment).
  2. Ro reaches out to your insurance and pulls coverage information.
  3. You get a written coverage report with estimated copays.
  4. If you proceed, Ro’s insurance concierge submits the PA to your insurance.
  5. If coverage is denied, Ro offers FDA-approved cash-pay options without making you start over with a new provider.

Ro pricing (verified May 23, 2026)

Membership: $39 for the first month, then $149/month. With annual prepay, as low as $74/month.

MedicationCash-Pay Price (if OptumRx doesn’t cover)
Wegovy pill$149–$299/month depending on dose
Wegovy pen$149–$349/month depending on dose; matched to NovoCare pricing
Zepbound KwikPen 2.5 mg$299/month with manufacturer offer
Zepbound KwikPen 5 mg$399/month with manufacturer offer
Zepbound KwikPen 7.5–15 mg$449/month with manufacturer offer (step-up to $499–$699 if refill window missed)
FoundayoAvailable at cash pricing matched to NovoCare — verify at ro.co/weight-loss/pricing
With OptumRx coverage + approved PAYour plan’s copay (typically Tier 3 or specialty tier)

The honest tradeoff with Ro

Ro does NOT bill its $39/$149 membership fee to OptumRx. That part is always cash-pay. Even if OptumRx covers your medication entirely, you’ll still pay Ro $39 the first month and then $149/month (or $74/month with annual prepay) for the program itself.

If what you want is an in-network telehealth visit billed directly to OptumRx, Ro is not that. The membership fee is the price you pay for the concierge that fights for medication coverage worth $800–$1,400/month at retail.

Ro contacts your insurance, returns a written report, and lets you decide before any membership fee. (sponsored)

Sesame Care: Best Broad FDA-Approved Alternative

Sesame Care is the strongest second option for OptumRx members who want provider choice and the broadest FDA-approved formulary in one place — including the new Wegovy pill, where Sesame is a NovoCare Recognized Care Provider. Sesame’s Success by Sesame program providers complete prior authorization paperwork on your behalf. One important catch: a one-off Sesame marketplace visit outside the Success by Sesame program cannot complete prior authorization per Sesame’s own FAQ.

What Sesame Care brings that Ro doesn’t

  • Wegovy pill via NovoCare partnership (announced January 2026) — one of the few telehealth platforms with a direct manufacturer-recognized relationship for oral Wegovy
  • Broadest FDA-approved formulary: Wegovy pen, Wegovy pill, Zepbound, Ozempic, Mounjaro, Foundayo, Saxenda
  • Costco-member pricing available on the weight-loss program
  • Provider choice — you pick your clinician from a marketplace rather than being auto-assigned

Sesame Care pricing (verified May 23, 2026)

  • Success by Sesame subscription: starts at $59/month with an annual subscription; $99/month month-to-month. Medication costs not included.
  • Self-pay branded medications: start at $149/month
  • With insurance + PA: GLP-1 medications as low as $25/month (depends on your plan and tier)
  • Initial labs: included in most states (not in AZ, HI, ND, NJ, NY, OK, RI, SD, WY)

Honest limitation

Sesame is not an OptumRx-named partner, so coverage still depends entirely on your OptumRx plan’s formulary and PA criteria. Enrollment in Success by Sesame is what unlocks PA help — a one-off Sesame visit does not.

See Sesame’s current GLP-1 program → (sponsored affiliate link, opens in a new tab)(sponsored)

Nurx: The Only Major Provider That Explicitly Lists OptumRx

Nurx is the only GLP-1 telehealth provider we found that explicitly names OptumRx in its medication insurance FAQ. Nurx says it accepts most private health insurance plans and pharmacy benefit managers — and lists OptumRx by name. Nurx’s medical consultation fee is cash-pay (insurance doesn’t cover the visit), but medication can be billed through your OptumRx pharmacy benefit if your plan covers it.

Most telehealth providers say “we accept insurance” without naming the PBM. Nurx is unusual: their FAQ specifically lists OptumRx. For an OptumRx member who wants verification before paying anything, that explicit listing is a small but real proof signal.

Nurx weight-management pricing (verified May 23, 2026)

  • Initial consult: one-time $79 charge
  • Ongoing care fee: $79/month
  • Branded GLP-1 medication: picked up at a local pharmacy (use your OptumRx pharmacy benefit if your plan covers it)
  • Oral medications: may use insurance, or $60–$329/month cash depending on medication
  • Government plans: Medicare, Medicaid, TRICARE, and CHAMPVA are not billed for these services

Limitation worth naming

Nurx’s OptumRx listing means your prescription can be routed through OptumRx pharmacy benefits — it does not mean your plan’s formulary will pay. You still need to confirm coverage on your specific plan. And if you want stronger PA advocacy and a coverage checker that reaches out to your insurance before you pay anything, Ro still does this better.

PlushCare, WeightWatchers Clinic, and Noom Med: Three Strong Alternatives

Three other providers earn a real spot when your situation points at them — none of them is the right default for most OptumRx members, but each has a clear lane.

PlushCare — Doctor-visit feel and broad insurance acceptance

PlushCare is a general telehealth primary-care platform that also prescribes GLP-1s. They handle prior authorization paperwork and are in-network with several major insurance carriers including UnitedHealthcare.

Pricing (verified May 23, 2026): $19.99/month membership or $149/year annual membership. Initial visits are $129 without insurance. With in-network insurance, PlushCare says most patients pay $30 or less per visit.

Honest limitation: PlushCare’s current OptumRx network status is not verifiable from PlushCare’s own public documentation as of May 2026. Some Reddit reports from 2024 mention UHC network changes. Confirm with PlushCare directly before enrolling. A class-action lawsuit in California alleges deceptive subscription enrollment and unauthorized charges after cancellation, and the BBB rating sits at 2.09/5 — set a calendar reminder on your billing date and watch the cancellation flow.

WeightWatchers Clinic (Med+) — Coaching plus medication

WeightWatchers Clinic offers GLP-1 prescribing with insurance coordinators who work with commercial plans (including UHC/OptumRx) to help cover medication. The registered dietitian service lists UnitedHealthcare among 600+ accepted plans.

Pricing (verified May 23, 2026): Promotional pricing on weightwatchers.com shows $55/month for the first three months with a 12-month plan, then $74/month ongoing. GLP-1 medication cost is not included.

Best fit: Members who want the WW behavioral program alongside the medication. Not the cheapest path; the most integrated lifestyle + clinical model.

Noom Med — Psychology coaching plus medication

Noom Med’s branded medications program sends your prescription to your preferred pharmacy (where you use OptumRx). Their care team assists with prior authorization (up to 14 days per Noom’s documentation).

Honest limitation: Noom Med’s branded meds program has state-specific availability. Confirm your state at noom.com before enrolling.

Calibrate: When Your Employer Plan Says You Have to Use Them First

Some OptumRx employer plans require Calibrate (or another structured weight-management program) before they’ll cover a GLP-1 for weight loss. OptumRx-hosted employer benefit pages confirm this. If your benefit materials say this, no other provider can shortcut it. Paying Ro or Sesame first won’t help; the plan will deny the PA until you’ve enrolled in the required program.

How to know if Calibrate is mandatory for you

Three signals:

  1. Your OptumRx member portal or HR benefits page mentions Calibrate by name for weight-management coverage
  2. The phrase “program participation” or “weight-management program enrollment” shows up in your formulary’s PA criteria
  3. A member services rep tells you that you need to complete a weight-management program before GLP-1 coverage

Calibrate is a structured 12-month weight-loss program that combines GLP-1 medication, coaching, and lifestyle changes. It’s heavier than a Ro membership — more meetings, more program structure, longer commitment. That’s not a flaw on plans that require it; it’s exactly what the employer paid for. If your plan doesn’t require Calibrate, start with Ro instead.

Does OptumRx Cover GLP-1 Medications in 2026?

Sometimes. OptumRx formularies are plan-specific, so the only way to know whether your specific plan covers Wegovy, Zepbound, Ozempic, Mounjaro, Foundayo, Rybelsus, or Saxenda is to check inside the OptumRx Drug Pricing tool for your member ID.

What to check in your OptumRx plan, by medication

MedicationOptumRx plan status to verifyTypical tier (varies)Approved FDA indication
Wegovy (semaglutide injection)Coverage, tier, PA, step therapy, quantity limitTier 3 or SpecialtyWeight loss; CV risk reduction (March 2024); MASH (August 2025)
Wegovy pill (oral semaglutide)Coverage rolling out 2026 — verify directlyTBDWeight loss
Zepbound (tirzepatide pen)Coverage, tier, PA, step therapyTier 3 or SpecialtyWeight loss; obstructive sleep apnea (December 2024)
Zepbound KwikPenSame as Zepbound pen; also used in Medicare GLP-1 Bridge (July 2026)SameSame
Ozempic (semaglutide)Coverage, tier, PATier 2–3Type 2 diabetes only
Mounjaro (tirzepatide)Coverage, tier, PATier 2–3Type 2 diabetes only
Foundayo (orforglipron)Being added to formularies in 2026 — verify directlyLikely Tier 3Weight loss (oral tablet)
Saxenda (liraglutide)Coverage, tier, PATier 2–3Weight loss (older option)
Rybelsus (oral semaglutide T2D)Coverage, tier, PATier 2Type 2 diabetes
Compounded semaglutide / tirzepatideGenerally not covered — verify with your planN/ACash-pay only

Sources: OptumRx Drug Pricing tool and member resources (optumrx.com); FDA approval records — Wegovy CV risk reduction (March 2024), Zepbound for OSA (December 2024), Wegovy MASH (August 2025), Wegovy oral (December 22, 2025), Foundayo/orforglipron (April 1, 2026); CMS Medicare GLP-1 Bridge program announcement (launches July 1, 2026).

Standard formulary ≠ your plan

OptumRx publishes commercial formularies, but every employer can configure their plan separately. Some employer plans exclude anti-obesity medications entirely, no matter what’s on OptumRx’s standard list. Even if Wegovy is on OptumRx’s commercial list, your specific plan might not pay for it. That’s why the verification step (next section) matters more than any provider claim.

Many GLP-1 medications require prior authorization on OptumRx plans, and step therapy and quantity limits are common. Compounded GLP-1s are generally not covered; verify directly with OptumRx member services if needed.

Want your specific OptumRx plan checked drug-by-drug? Start Ro ’s free coverage report → (sponsored affiliate link, opens in a new tab)(sponsored)

How to Verify Your OptumRx GLP-1 Coverage in Under 10 Minutes

Before paying any telehealth provider a membership fee, spend 10 minutes inside OptumRx confirming three things: (1) does your plan include weight-loss medication coverage, (2) which specific GLP-1s are covered, and (3) what tier and PA requirements apply. Most provider memberships are non-refundable once enrolled — verifying first prevents the most common and most expensive mistake people make.

  1. 1

    Confirm OptumRx is actually your PBM.

    Look at your insurance card. Your medical insurance might be UHC, Aetna, Anthem, or another carrier. The PBM is OptumRx if “OptumRx” appears anywhere on the card, or if you have a separate OptumRx card. Look for RxBIN, RxPCN, and RxGRP codes — those identify your pharmacy benefit.

  2. 2

    Log into optumrx.com (or the OptumRx app).

    Your OptumRx login is separate from your medical insurance login. If you can’t log in, your account isn’t activated — call the number on your card and ask member services to walk you through it.

  3. 3

    Use the Drug Pricing tool and search each medication separately.

    Search: Wegovy, Wegovy pill, Zepbound, Zepbound KwikPen, Ozempic, Mounjaro, Foundayo, Saxenda. The tool shows one of three results:

    • “Covered with prior authorization” → your plan includes it; you’ll need PA
    • “Not covered” or “Excluded” → your employer didn’t opt in for this drug
    • “Drug not listed” → usually means excluded; confirm with member services

    Take screenshots of each result. Date them.

  4. 4

    Call OptumRx member services and ask these 5 questions.

    The number is on your card. Have your medication and screenshots ready. Ask:

    1. Is this medication covered for obesity or chronic weight management under my plan?
    2. Is coverage limited to type 2 diabetes, cardiovascular risk reduction, sleep apnea, MASH, or another indication?
    3. What are the prior-authorization criteria?
    4. Does my plan require Calibrate, Noom, or another weight-management program before coverage?
    5. Will dose increases or renewals require a new PA?

    Write down the reference number for the call. You’ll need it if something contradicts what you were told.

  5. 5

    Use a provider-side coverage tool if you want help.

    Ro’s GLP-1 Insurance Coverage Checker reaches out to your insurance and returns a written report. Free. No prescription submitted. No commitment.

OptumRx Prior Authorization: What PreCheck Does (And Doesn’t Do) for GLP-1s

OptumRx automated parts of its prior authorization workflow in 2024 with PreCheck Prior Authorization, which can automate PA for select drugs — including GLP-1s for diabetes — when the request is in scope and the prescriber’s EMR has the required clinical data. Per UnitedHealth Group, in-scope PreCheck submissions have a median approval time of 29 seconds. Important caveat: do not assume every GLP-1 weight-loss PA is eligible for PreCheck automation. Many PAs still go through standard review (typically decided within 15 calendar days for non-urgent requests).

What boosts your chance of a smooth PA

  • Documented BMI ≥ 30, or BMI ≥ 27 with at least one weight-related comorbidity (type 2 diabetes, high blood pressure, dyslipidemia, obstructive sleep apnea, cardiovascular disease)
  • Proper ICD-10 coding for obesity or the qualifying comorbidity
  • Documented prior weight-loss efforts (lifestyle interventions, diet, exercise, behavioral counseling)
  • The drug matches the indication (Wegovy/Zepbound/ Foundayo for weight loss; Ozempic/Mounjaro for T2D)
  • Patient meets age criteria (18+ typical; Wegovy has separate criteria for ages 12+)

What slows things down or causes denials

  • BMI missing or vague in the chart
  • Wrong drug for the indication (e.g., Ozempic prescribed for weight loss when your plan limits it to T2D)
  • No documented prior weight-loss attempts
  • Step therapy not satisfied — your plan wants you to try a less expensive option first
  • Concurrent prescription of another GLP-1 (most plans won’t cover two GLP-1s at once)
  • Documentation lag — PA submitted before BMI or labs were updated in the chart

Step therapy on OptumRx plans

Some OptumRx plans require step therapy — meaning you may need to document failure or intolerance of a less expensive medication before Wegovy or Zepbound is approved. Common front-line options include phentermine, orlistat, or older GLP-1s like Saxenda. Providers with experienced insurance teams know how to document step-therapy exceptions when they apply.

For a deeper look at PA support across providers, see GLP-1 Providers That Help With Prior Authorization.

What You’ll Actually Pay With OptumRx: Tier-by-Tier Reality

Even with OptumRx coverage and an approved PA, your real out-of-pocket cost depends on your specific plan’s tier for your specific GLP-1. Real-world copays typically run $25–$200/month with active coverage; without coverage, retail prices run $800–$1,400/month.

OptumRx tier structure on most commercial plans

TierWhat it isTypical examplesApproximate copay
Tier 1 — Preferred genericLowest copayGeneric metformin, generic phentermine$5–$25/month
Tier 2 — Preferred brandLower brand copayOzempic, Mounjaro (often), Rybelsus$25–$80/month
Tier 3 — Non-preferred brandHigher brand copayWegovy, Zepbound (commonly), Saxenda$80–$200/month
Specialty tierHighest tier or % coinsuranceSome Wegovy/Zepbound placements$150–$300/month or 20–30% coinsurance

Tier placement varies by plan. Verify your specific plan inside OptumRx before assuming any cost figure.

Two levers that change your real copay

1. Tier placement matters more than people think.

Before your prescriber writes the script, ask member services: is Zepbound preferred over Wegovy on my plan, or vice versa? Choosing the preferred option can save $50–$100/month. If your plan prefers Wegovy and your prescriber writes Zepbound (or vice versa), you’ll pay more than you need to.

2. Manufacturer savings cards stack with commercial coverage.

Novo Nordisk (Wegovy, Ozempic, Saxenda) and Eli Lilly (Zepbound, Mounjaro) offer copay cards that work alongside commercial OptumRx coverage. They can reduce your copay significantly if your plan covers the medication. These savings cards do not work with Medicare, Medicaid, TRICARE, CHAMPVA, or other government-funded plans.

Want your exact OptumRx copay estimate? Get Ro’s free drug-by-drug coverage report → (sponsored affiliate link, opens in a new tab)(sponsored)

Your OptumRx GLP-1 Prior Authorization Readiness Checklist

OptumRx denies a meaningful share of PAs for documentation gaps, not clinical ineligibility. Walking into your first telehealth visit with the right paperwork can be the difference between a fast approval and a 14-day back-and-forth.

Pull these together before your first visit

  • Current height, weight, and BMI (within the last 30 days if possible)
  • Brief weight history with rough dates (e.g., 175 lb at age 25, 215 lb today)
  • Any related conditions: type 2 diabetes, high blood pressure, high cholesterol, sleep apnea, cardiovascular disease, MASH/fatty liver
  • A1C reading if you have or are testing for type 2 diabetes
  • Sleep study results if you have obstructive sleep apnea
  • Current medications list
  • Documented prior weight-loss efforts (diet program, exercise routine, prior medication, prior surgery if applicable)
  • Insurance card (front and back)
  • Pharmacy benefit card if separate from medical card
  • OptumRx Drug Pricing screenshot showing your medication’s status, tier, and PA requirement
  • RxBIN, RxPCN, RxGRP, member ID
  • Prior denial letter if you’ve already been denied

What not to do

Don’t ask a telehealth provider to “just prescribe Ozempic for weight loss.” Ozempic is FDA-approved only for type 2 diabetes. If your plan limits Ozempic to T2D, that PA is likely to fail. Ask the clinician which FDA-approved medication and indication pathway is clinically appropriate for your situation and compatible with your plan.

What to Do If OptumRx Denies Your GLP-1 Prior Authorization

An OptumRx denial isn’t one thing. Six common denial types each call for a different response. The matrix below tells you which one you’re in.

The OptumRx GLP-1 Denial Decision Matrix

Denial typeWhat it actually meansYour best next step
Missing or incomplete documentationBMI, comorbidity, or prior-effort docs weren’t in your chart at submissionHave your prescriber resubmit with complete records; ask about peer-to-peer review if denied again
Wrong drug for indicationE.g., Ozempic prescribed for weight loss when your plan limits it to T2DAsk the clinician about an FDA-approved alternative for your actual diagnosis
Step therapy not satisfiedPlan wants you to try a less expensive option first (phentermine, orlistat, Saxenda)Document trial-and-failure or contraindication; provider submits step-therapy exception
Non-formulary statusYour specific GLP-1 isn’t on your plan’s drug listSwitch to a covered alternative or request a formulary exception
Weight-loss medication exclusionYour employer plan excludes anti-obesity meds entirelyCheck exception indications (CV risk for Wegovy, OSA for Zepbound, T2D for Ozempic/Mounjaro); ask the plan about an exception process; otherwise consider the cash-pay path
Renewal or dose-change denialPlan wants documented response data before refilling or moving up dosesProvider submits updated weight, side-effect, and response documentation

Exception paths that can work even when weight-loss is excluded

  • Wegovy for cardiovascular risk reduction — covered on a non-formulary pathway when you have established CVD. FDA-approved March 2024.
  • Wegovy for MASH (metabolic dysfunction-associated steatohepatitis) — FDA-approved August 2025 for adults with MASH with moderate-to-advanced fibrosis, excluding cirrhosis.
  • Zepbound for obesity with obstructive sleep apnea — requires a documented sleep study. FDA expanded Zepbound for OSA December 2024.
  • Ozempic or Mounjaro for type 2 diabetes — standard PA pathway with documented T2D diagnosis.

Should you appeal or move on?

Denial reasonAppeal?
Incomplete documentationYes — resubmit cleanly
Step therapy not metYes — document exception
Wrong drugNo — switch drug
Plan-level anti-obesity exclusionUsually low-yield unless an exception process exists or a different FDA-approved indication applies
True clinical ineligibilityNo — work with prescriber on alternatives

One thing about waiting: You don’t have to wait while you appeal. Ro and Sesame both let you start a cash-pay path while your insurance appeal is in process — no need to restart enrollment if the appeal eventually succeeds.

For your appeal paperwork, see our GLP-1 Medical Necessity Letter: 6-Point Checklist.

Cash-Pay Fallback: When Your OptumRx Plan Excludes Weight-Loss GLP-1s

If your OptumRx plan excludes weight-loss medications and no exception path applies, cash-pay programs are the realistic next step. These providers do not interact with OptumRx at all — they exist for members whose plans don’t pay for anti-obesity GLP-1s.

FDA-grade compounded disclosure you should read first

Compounded GLP-1 medications are not FDA-approved. FDA does not verify the safety, effectiveness, or quality of compounded drugs before they are marketed. Compounded drugs should generally be used only when a patient’s medical needs cannot be met by an FDA-approved drug. Licensed providers can prescribe them and licensed US pharmacies can dispense them, but they have not gone through FDA evaluation for safety, effectiveness, or manufacturing quality the way Wegovy or Zepbound have. We present these options as a clearly distinct category — never as substitutes for branded medications. (Source: FDA, Compounding and the FDA: Questions and Answers.)

Eden — Clinical-feel cash-pay

Eden is a cash-pay-only GLP-1 provider with a clinical aesthetic, licensed clinicians, and transparent pricing. Eden does not accept commercial insurance per its terms of service.

  • Compounded semaglutide: $149 first month, $249/month ongoing
  • Compounded tirzepatide: also available
  • Insurance status: cash-pay only
  • Best for: OptumRx members whose plans exclude weight-loss meds and who want a more “medical practice” feel

Cash-pay only · compounded — not FDA-approved

MEDVi — Cash-pay option that requires extra regulatory disclosure

FDA warning letter (February 20, 2026): FDA issued a warning letter to MEDVi, LLC dated February 20, 2026, stating FDA had reviewed MEDVi’s website and found false or misleading claims concerning compounded semaglutide and tirzepatide products — including claims that implied FDA approval or evaluation, and language equating compounded products with FDA-approved branded medications. The warning letter is public on FDA’s website (FDA warning letter #721455). If you’re considering MEDVi, verify the current website, labeling, pharmacy source, and correction status directly with MEDVi and against FDA’s current published warning-letter status before enrolling.

A note on HSA and FSA

Cash-pay GLP-1 medication prescribed for a diagnosed condition is generally HSA/FSA-eligible. Program/membership fees may or may not qualify — check with your plan administrator before enrolling. Pre-tax savings effectively reduce out-of-pocket cost by 20–35% depending on your tax bracket.

For a broader cost view, see our GLP-1 Cost Without Insurance guide.

What Real OptumRx Members Sound Like Before They Find a Provider

In r/Zepbound, r/WegovyWeightLoss, and r/glp1, a few themes show up over and over:

  • Every plan is different, even within the same insurer. One person gets approved in a week; another waits two months on identical insurance.
  • The portal, member services, and the pharmacy give contradictory information. People end up calling everyone twice.
  • The denial reason isn’t always clear. Patients see “not approved” with no explanation of what failed.
  • Dose increases sometimes trigger fresh PA work that no one warned them about.
  • “Covered with the proper PA” turns out to mean a lot of paperwork from the prescriber’s side.

If you’ve felt any of this, you’re not alone — and it’s usually not the medication or your eligibility that’s the problem. It’s that nobody told you OptumRx is a PBM, your plan rules are separate from your prescriber, and the documentation submitted to OptumRx is what actually decides the outcome. That’s why provider choice matters more than the cheapest membership.

Methodology: How We Classified Every Provider on This Page

Every provider on this page was scored against five OptumRx-specific criteria using public documentation, provider terms of service, OptumRx member resources, FDA approval data, FDA warning letters, and CMS announcements. Where we couldn’t verify a claim from current public sources, the row is flagged. We re-audit this page monthly.

The five OptumRx-specific scoring criteria

  1. Prescribes FDA-approved GLP-1s — provider must offer Wegovy, Zepbound, Ozempic, Mounjaro, Saxenda, or Foundayo. Compounded-only providers are scored separately.
  2. Submits prior authorization — provider must have a documented PA workflow that includes OptumRx submissions.
  3. Active insurance concierge — provider must employ a team that handles denials, appeals, and follow-up, not just initial PA submissions.
  4. Routes prescriptions through OptumRx pharmacy network — provider must let patients fill at any OptumRx-network pharmacy (retail, OptumRx Home Delivery, or OptumRx Specialty Pharmacy).
  5. Cash-pay fallback if OptumRx denies — does the same provider offer a cash-pay option without restarting enrollment?

What we could not verify (and you should confirm directly)

  • Whether your specific OptumRx plan will accept any specific provider
  • Whether your GLP-1 prior authorization will be approved
  • Whether your employer plan requires Calibrate, Noom Med, or another weight-management program
  • PlushCare’s current OptumRx in-network status — confirm with PlushCare directly
  • Whether a provider’s PA support applies to every medication, state, and plan
  • Wegovy pill formulary tier on every OptumRx plan (rolling out through 2026)
  • Foundayo formulary placement on specific OptumRx plans
  • Noom Med specific state availability — confirm at noom.com

Frequently Asked Questions

Does OptumRx cover GLP-1 medications in 2026?

Sometimes. OptumRx formularies are plan-specific. OptumRx has historically included Wegovy, Saxenda, Zepbound, Ozempic, and Mounjaro on commercial drug lists, and is adding Wegovy pill and Foundayo through 2026. Whether your plan pays depends on whether your employer opted into anti-obesity medication coverage and whether you meet the PA criteria. Verify directly in the OptumRx Drug Pricing tool before paying any telehealth provider.

Does OptumRx cover Wegovy?

Depends on your specific plan. OptumRx has historically included Wegovy on its commercial drug list. Coverage on your plan depends on (a) whether your employer opted into anti-obesity meds, and (b) meeting OptumRx’s PA criteria (BMI ≥30 or ≥27 with a comorbidity, documented prior weight-loss efforts, proper ICD-10 coding). Wegovy also has FDA-approved indications for cardiovascular risk reduction (approved March 2024) and MASH (approved August 2025), which can sometimes open coverage when weight-loss alone is excluded.

Does OptumRx cover Zepbound?

Depends on your plan. OptumRx has historically included Zepbound on its commercial drug list — notably keeping Zepbound when some other PBMs removed it. Coverage on your specific plan depends on employer opt-in. Zepbound also has a separate FDA-approved indication for obesity with obstructive sleep apnea (expanded December 2024), which is sometimes a coverage path when weight-loss alone isn’t.

Does OptumRx cover Ozempic for weight loss?

Probably not. Ozempic is FDA-approved for type 2 diabetes, not chronic weight management. Most plans limit Ozempic coverage to its labeled indication, so a PA for Ozempic-for-weight-loss is likely to fail. If you have documented type 2 diabetes, Ozempic is typically covered with PA. If your goal is weight loss specifically, ask the clinician about Wegovy, Zepbound, or Foundayo instead.

Does OptumRx cover Foundayo (the new oral GLP-1)?

Coverage is rolling out. Foundayo (orforglipron) was FDA-approved on April 1, 2026, and is being added to select OptumRx formularies through 2026. Check the OptumRx Drug Pricing tool for your specific plan.

Does Ro accept OptumRx?

Ro doesn’t publish an “accepts OptumRx” list. What Ro does is run a free GLP-1 Insurance Coverage Checker that reaches out to your insurance and returns a written coverage report, and an insurance concierge that submits prior authorization paperwork. Your Ro Body membership ($39 first month, then $149/month, or $74/month with annual prepay) is cash-pay and not billed to OptumRx; the medication itself is filled through your pharmacy benefit if your plan covers it.

Does Sesame Care accept OptumRx?

Sesame doesn’t publish an OptumRx-specific list, but Sesame’s Success by Sesame program providers complete prior authorization paperwork on your behalf for medication coverage. Sesame is also a NovoCare Recognized Care Provider for the Wegovy pill (announced January 2026). A one-off Sesame marketplace visit outside the Success by Sesame program cannot complete PA per Sesame’s published FAQ.

Does Nurx accept OptumRx?

Yes — Nurx’s insurance FAQ explicitly lists OptumRx among accepted private insurance plans and pharmacy benefit managers for medications. Nurx’s medical consultation fee is cash-pay ($79 initial, $79/month ongoing), and the medication itself can be billed through your OptumRx pharmacy benefit if your plan covers it. Government insurance (Medicare, Medicaid, TRICARE, CHAMPVA) is not billed for these services.

Can an online provider submit OptumRx prior authorization?

Yes. Ro, Sesame’s Success by Sesame, Nurx, PlushCare, WeightWatchers Clinic, Noom Med, and Calibrate all submit prior authorization. The plan still decides whether to approve, and the strength of the documentation matters more than the provider’s name.

How long does OptumRx prior authorization take?

OptumRx PreCheck Prior Authorization can automate PA for select drugs (including GLP-1s for diabetes) when the request is in scope and the prescriber’s EMR has the required clinical data — with a median approval time of 29 seconds when it auto-approves. Requests that fall to standard review are typically decided within 15 calendar days for non-urgent submissions. Requests with incomplete documentation can take longer because they bounce back for more information.

What if my OptumRx plan excludes weight-loss medications?

First, check the FDA-approved exception indications: Wegovy for cardiovascular risk reduction, Wegovy for MASH, Zepbound for obstructive sleep apnea, Ozempic or Mounjaro for type 2 diabetes. These pathways may apply even when weight-loss drugs are excluded. Ask your plan whether an exception process exists. If none of these apply, cash-pay compounded programs are a fallback — read the compliance disclosures in our cash-pay section carefully before choosing one.

What if my OptumRx employer plan requires Calibrate?

Use Calibrate first. Some OptumRx-hosted employer benefit pages specifically require Calibrate enrollment for GLP-1 weight-loss medication coverage. No other provider can shortcut this — the plan will deny the PA until you’ve completed the program enrollment. Once you’ve enrolled in Calibrate (or whichever weight-management program your plan requires), the coverage pathway opens.

Does OptumRx cover compounded GLP-1s?

Do not assume coverage. This page is focused on the OptumRx pharmacy-benefit route for FDA-approved medications. Compounded programs are generally cash-pay; verify with your specific plan before assuming anything. Compounded GLP-1 medications are not FDA-approved.

What’s the difference between OptumRx and UnitedHealthcare?

UnitedHealthcare is the health insurance company. OptumRx is the pharmacy benefit manager. Both are owned by UnitedHealth Group. Your card might show UHC for medical and OptumRx for pharmacy benefits. OptumRx also services some non-UHC plans. For the broader UHC view, see our UnitedHealthcare GLP-1 guide.

Does OptumRx Medicare cover GLP-1s for weight loss?

Not as of mid-2026 for weight loss alone. Medicare Part D excludes GLP-1s for weight loss by federal statute through June 2026. The CMS Medicare GLP-1 Bridge program launches July 1, 2026, covering Wegovy, Zepbound KwikPen, and Foundayo at $50/month for eligible Part D beneficiaries through December 2027. Medicare-covered indications today are limited to type 2 diabetes (Ozempic, Mounjaro), OSA (Zepbound on some MA-PD plans), and CV risk reduction (Wegovy on some plans).

Can I use HSA or FSA for cash-pay GLP-1 programs?

GLP-1 medication prescribed for a diagnosed condition generally qualifies for HSA/FSA reimbursement. Program/membership fees may or may not qualify depending on your plan administrator. Check before enrolling.

What if my OptumRx portal says my drug is covered but the pharmacy denies the claim?

This usually means a prior authorization was required and wasn’t on file at the time you tried to fill the prescription. Ask the pharmacy to send a “PA needed” message back to your prescriber. Your prescriber (or your telehealth provider’s insurance team) submits the PA to OptumRx. Once approved, refill the prescription. Don’t pay out of pocket assuming the denial is final — most “denials” at the counter are missing-PA situations, not true denials.

Bottom Line: Which GLP-1 Provider Should You Use With OptumRx?

For most commercial OptumRx members trying to get an FDA-approved GLP-1 covered, start with Ro’s free Coverage Checker. If you want the broadest FDA-approved formulary or specifically want the new Wegovy pill, Sesame’s Success by Sesame is the strongest alternative. If you want a provider that explicitly lists OptumRx in their insurance FAQ, Nurx is the cleanest match. If your employer plan requires Calibrate, you have to start there. And if your plan excludes weight-loss meds with no exception path, read the cash-pay section above before clicking anything.

Your situationBest next step
Commercial OptumRx, want PA help and a coverage checkRo
Want provider choice + access to the Wegovy pillSesame Care (Success by Sesame)
Want a provider that explicitly lists OptumRx by nameNurx
Want a doctor-visit feel and broad insurance acceptancePlushCare (verify current OptumRx network status)
Want coaching alongside the medicationWeightWatchers Clinic or Noom Med
Employer plan requires Calibrate firstCalibrate
Already have a great PCP with good recordsPCP + a provider that submits PA
OptumRx denied — figure out denial type firstSee denial matrix above; then Medical Necessity Letter checklist
OptumRx plan excludes weight-loss meds and no exception pathRead cash-pay section above carefully (Eden, MEDVi disclosures included)

Ro and Sesame Care links are sponsored. No email required for the quiz.

Why We Wrote This Page (And How to Trust It)

The RX Index is a pricing intelligence and comparison resource for GLP-1 telehealth providers. We don’t sell medications and we don’t operate a clinic. We compare what other companies offer, verify what they claim, and tell you what we found and what we couldn’t verify.

Some of the links on this page are affiliate links. We may earn a commission if you enroll through one. That doesn’t change what you pay, it doesn’t change which providers we cover, and it doesn’t change how we rank them.

This page was written and verified by The RX Index Editorial Team on May 23, 2026. We re-audit it monthly. If you find outdated information, email us and we’ll update within 48 hours.

Important medical disclaimer: This page is informational. It is not medical advice. Always work with a licensed clinician to determine whether a GLP-1 medication is appropriate for you. FDA-approved GLP-1 labels include boxed warnings for thyroid C-cell tumors and other risks; eligibility and prescribing decisions belong to a licensed clinician who knows your medical history. Compounded medications are not FDA-approved.

Last verified: May 23, 2026 · Next scheduled verification: June 23, 2026, with additional refresh when OptumRx updates its commercial formulary for the second half of 2026.